Onida F - Search Results

1

Prognostic factors and risk assessment in chronic myelomonocytic leukemia: validation study of the M.D. Anderson Prognostic Scoring System.

Beran M, Wen S, Shen Y, Onida F, Jelinek J, Cortes J, Giles F, Kantarjian H. Beran M, et al. Among authors: onida f. Leuk Lymphoma. 2007 Jun;48(6):1150-60. doi: 10.1080/10428190701216386. Leuk Lymphoma. 2007. PMID: 17577778

2

Effects of signal transduction inhibitor 571 in acute myelogenous leukemia cells.

Scappini B, Onida F, Kantarjian HM, Dong L, Verstovsek S, Keating MJ, Beran M. Scappini B, et al. Among authors: onida f. Clin Cancer Res. 2001 Dec;7(12):3884-93. Clin Cancer Res. 2001. PMID: 11751479

3

Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients.

Onida F, Kantarjian HM, Smith TL, Ball G, Keating MJ, Estey EH, Glassman AB, Albitar M, Kwari MI, Beran M. Onida F, et al. Blood. 2002 Feb 1;99(3):840-9. doi: 10.1182/blood.v99.3.840. Blood. 2002. PMID: 11806985 Free article.

4

In vitro effects of STI 571-containing drug combinations on the growth of Philadelphia-positive chronic myelogenous leukemia cells.

Scappini B, Onida F, Kantarjian HM, Dong L, Verstovsek S, Keating MJ, Beran M. Scappini B, et al. Among authors: onida f. Cancer. 2002 May 15;94(10):2653-62. doi: 10.1002/cncr.10543. Cancer. 2002. PMID: 12173333 Free article.

5

Characteristics and outcome of patients with Philadelphia chromosome negative, bcr/abl negative chronic myelogenous leukemia.

Onida F, Ball G, Kantarjian HM, Smith TL, Glassman A, Albitar M, Scappini B, Rios MB, Keating MJ, Beran M. Onida F, et al. Cancer. 2002 Oct 15;95(8):1673-84. doi: 10.1002/cncr.10832. Cancer. 2002. PMID: 12365015 Free article.

6

Mutation in the ATP-binding pocket of the ABL kinase domain in an STI571-resistant BCR/ABL-positive cell line.

Ricci C, Scappini B, Divoky V, Gatto S, Onida F, Verstovsek S, Kantarjian HM, Beran M. Ricci C, et al. Among authors: onida f. Cancer Res. 2002 Nov 1;62(21):5995-8. Cancer Res. 2002. PMID: 12414617

7

Contribution of beta-2 microglobulin levels to the prognostic stratification of survival in patients with myelodysplastic syndrome (MDS).

Gatto S, Ball G, Onida F, Kantarjian HM, Estey EH, Beran M. Gatto S, et al. Among authors: onida f. Blood. 2003 Sep 1;102(5):1622-5. doi: 10.1182/blood-2002-10-3264. Epub 2003 May 8. Blood. 2003. PMID: 12738677 Free article.

8

The proteasome inhibitor PS-341 inhibits growth and induces apoptosis in Bcr/Abl-positive cell lines sensitive and resistant to imatinib mesylate.

Gatto S, Scappini B, Pham L, Onida F, Milella M, Ball G, Ricci C, Divoky V, Verstovsek S, Kantarjian HM, Keating MJ, Cortes-Franco JE, Beran M. Gatto S, et al. Among authors: onida f. Haematologica. 2003 Aug;88(8):853-63. Haematologica. 2003. PMID: 12935973

9

Changes associated with the development of resistance to imatinib (STI571) in two leukemia cell lines expressing p210 Bcr/Abl protein.

Scappini B, Gatto S, Onida F, Ricci C, Divoky V, Wierda WG, Andreeff M, Dong L, Hayes K, Verstovsek S, Kantarjian HM, Beran M. Scappini B, et al. Among authors: onida f. Cancer. 2004 Apr 1;100(7):1459-71. doi: 10.1002/cncr.20131. Cancer. 2004. PMID: 15042680 Free article.

10

Allogeneic transplantation: a therapeutic option for myelofibrosis, chronic myelomonocytic leukemia and Philadelphia-negative/BCR-ABL-negative chronic myelogenous leukemia.

Mittal P, Saliba RM, Giralt SA, Shahjahan M, Cohen AI, Karandish S, Onida F, Beran M, Champlin RE, de Lima M. Mittal P, et al. Among authors: onida f. Bone Marrow Transplant. 2004 May;33(10):1005-9. doi: 10.1038/sj.bmt.1704472. Bone Marrow Transplant. 2004. PMID: 15048141

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

160 results

Search Page

Filters